2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 13: International Comparisons

Data Source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. All rates are unadjusted. Data for Indonesia represent the West Java region. Data for France include 22 regions. Data for Spain include 18 of 19 regions. Abbreviations: ESRD, end-stage renal disease. Figure 13.1 Geographic variations in the incidence of treated ESRD per million population, by country, 2013 Vol 2, ESRD, Ch 132

Data Source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. All rates are unadjusted. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Belgium do not include patients younger than 20. Data for Indonesia represent the West Java region. Data for France include 22 regions. Data for Spain include 18 of 19 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.2 Incidence of treated ESRD, per million population, by country, 2013 Vol 2, ESRD, Ch 133

Data Source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Data for Croatia are missing from , indicated by the dashed line. Data for U.S. are shown for comparison purposes. Abbreviations: ESRD, end-stage renal disease. Figure 13.3 Trends in the incidence of treated ESRD, per million population, by country, Vol 2, ESRD, Ch 134 Ten countries having the highest % rise in ESRD incidence rate from 2000/01 to 2012/13, plus the U.S. Five countries having the largest % decline in ESRD incidence rate from 2000/01 to 2012/13 Data Source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Abbreviations: ESRD, end-stage renal disease.

Table 13.1 Trends in the incidence of treated ESRD, per million population, by country, Vol 2, ESRD, Ch 135 Country % change from 2000/01 to 2012/13 Argentina Australia Austria Bahrain Bangladesh Belgium, Dutch sp Belgium, French sp Bosnia and Herzegovina Brazil Canada Chile Colombia Croatia Czech Republic Denmark Estonia Finland France Greece Hong Kong Hungary Iceland Indonesia Iran Ireland Israel Italy Jalisco (Mexico) Japan (Continue on the next slide)

Table 13.1 Trends in the incidence of treated ESRD, per million population, by country, (Continued) Vol 2, ESRD, Ch 136 Country % change from 2000/01 to 2012/13 Rep. of Korea Malaysia Morelos (Mexico) Netherlands New Zealand Norway Oman Philippines Poland Portugal Qatar Romania Russia Saudi Arabia Scotland Serbia Singapore Slovenia Spain Sweden Switzerland Taiwan Thailand Turkey Ukraine United Kingdom^ United States Uruguay Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. Incidence is unadjusted. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Japan and Taiwan include dialysis only. Data for France include 15 regions in 2006, 18 regions in 2007, 20 regions in 2008, and 22 regions in Data for Spain include 18 of 19 regions. Data for Belgium do not include patients younger than 20. Data for Indonesia represent the West Java region. a % change is calculated as the percent difference between the average incidence in 2012 and 2013 and the average in 2000 and Abbreviations: ESRD, end-stage renal disease; sp., speaking;. signifies data not reported.

Data Source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Spain include 18 of 19 regions. Data for France include 22 regions. Data for Indonesia represent the West Java region. Data for Belgium do not include patients younger than 20. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.4 Percentage of incident ESRD patients with diabetes as the primary ESRD cause, by country, 2013 Vol 2, ESRD, Ch 137

Data Source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Data presented only for countries from which relevant information was available. Data for U.S. are shown for comparison purposes. Abbreviations: ESRD, end-stage renal disease. Figure 13.5 Trends in the incidence of treated ESRD due to diabetes, per million population, Vol 2, ESRD, Ch 138 Ten countries having the highest % rise from 2000/01 to 2012/13, plus the U.S.

Table 13.2 Trends in the incidence of treated ESRD due to diabetes, per million population, Vol 2, ESRD, Ch 139 Country % change from 2000/01 to 2012/13 Argentina Australia Austria Bahrain Belgium, Dutch sp Belgium, French sp Bosnia and Herzegovina Brazil Canada Chile Colombia Croatia Czech Republic Denmark Estonia Finland France Greece Hong Kong Hungary Iceland Iran Israel Italy Jalisco (Mexico) Japan Rep. of Korea Malaysia (Continue on the next slide)

Data source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Data presented only for countries from which relevant information was available. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for France include 15 regions in 2006, 18 regions in 2007, 20 regions in 2008, and 22 regions in Data for Spain include 18 of 19 regions. Data for Belgium do not include patients younger than 20. a % change is calculated as the percent difference between the average incidence in 2012 and 2013 and the average in 2000 and Abbreviations: ESRD, end- stage renal disease. Table 13.2 Trends in the incidence of treated ESRD due to diabetes, per million population, (Continued) Vol 2, ESRD, Ch 1310 Country % change from 2000/01 to 2012/13 Morelos (Mexico) Netherlands New Zealand Norway Oman Philippines Poland Portugal Qatar Romania Russia Saudi Arabia Scotland Serbia Singapore Slovenia Spain Sweden Switzerland Taiwan Thailand Turkey Ukraine United Kingdom^ United States Uruguay

Data source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Data presented only for countries from which relevant information was available. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Spain include 18 of 19 regions; Data for France include 22 regions. For graph (a) data for Spain include patients years old, and data for the United States include patients years old. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.6 Incidence of treated ESRD, per million population, by age group and country, 2013 Vol 2, ESRD, Ch 1311 (a) years old

Data source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Data presented only for countries from which relevant information was available. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Spain include 18 of 19 regions; Data for France include 22 regions. For graph (a) data for Spain include patients years old, and data for the United States include patients years old. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.6 Incidence of treated ESRD, per million population, by age group and country, 2013 Vol 2, ESRD, Ch 1312 (a) years old

Data source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Data presented only for countries from which relevant information was available. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Spain include 18 of 19 regions; Data for France include 22 regions. For graph (a) data for Spain include patients years old, and data for the United States include patients years old. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.6 Incidence of treated ESRD, per million population, by age group and country, 2013 Vol 2, ESRD, Ch 1313 (a) years old

Data source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Data presented only for countries from which relevant information was available. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Spain include 18 of 19 regions; Data for France include 22 regions. For graph (a) data for Spain include patients years old, and data for the United States include patients years old. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.6 Incidence of treated ESRD, per million population, by age group and country, 2013 Vol 2, ESRD, Ch 1314 (a) ≥ 75 years old

Data source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Data presented only for countries from which relevant information was available. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Belgium do not include patients younger than 20. Data for Spain include 18 of 19 regions. Data for France include 22 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.7 Incidence of treated ESRD, per million population, by sex and country, 2013 Vol 2, ESRD, Ch 1315

Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. The prevalence is unadjusted and reflects prevalence at the end of ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Japan and Taiwan include dialysis patients only. Data for Belgium do not include patients younger than 20. Data for Indonesia represent the West Java region. Data for Spain include 18 of 19 regions. Data for France include 22 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Vol 2, ESRD, Ch 1316 Figure 13.8 Prevalence of treated ESRD, per million population, by country, 2013

Vol 2, ESRD, Ch 1317 Table 13.3 Number of prevalent ESRD patients and prevalence of ESRD, per million population, by country, (a)ESRD prevalence, per million population Country % change from 2000/01 to 2012/13 Argentina Australia Austria Bahrain Bangladesh Belgium, Dutch sp Belgium, French sp Bosnia and Herzegovina Brazil Canada Chile Colombia Croatia Czech Republic Denmark Estonia Finland France Greece Hong Kong Hungary Iceland Indonesia Iran Ireland Israel Jalisco (Mexico) Japan Rep. of Korea Lebanon (Continue on the next slide)

Vol 2, ESRD, Ch 1318 Table 13.3 Number of prevalent ESRD patients and prevalence of ESRD, per million population, by country, (Continued) (a)ESRD prevalence, per million population Country % change from 2000/01 to 2012/13 Malaysia Netherlands New Zealand Norway Oman Philippines Poland Portugal Qatar Romania Russia Saudi Arabia Scotland Serbia Singapore Slovenia South Africa Spain Sweden Taiwan Thailand Turkey Ukraine United Kingdom^ United States Uruguay (Continue on the next slide)

Vol 2, ESRD, Ch 1319 Table 13.3 Number of prevalent ESRD patients and prevalence of ESRD, per million population, by country, (Continued) (Continue on the next slide) (a)Prevalent patients, counts Country Argentina....21,03422,33323,30624,21830,03530,58031,88531,97534,21836,290 Australia11,65712,31813,01713,69114,27515,17516,11216,84217,82618,51019,21219,90920,74221,470 Austria5,7706,0916,3036,9406,9257,2327,5127,7317,8988,1958,3258,4328,6578,906 Bahrain Bangladesh6,7467,5378,2659,22010,27411,56512,86415,08917,06816,06817,08016,05018,92218,900 Belgium, Dutch sp.4,7004,9755,2605,4645,7286,0236,3006,5316,7797,0947,3097,4977,6777,823 Belgium, French sp..3,5833,8504,0684,3354,5164,7684,9835,1845,1515,3785,5665,7956,005 Bosnia and Herzegovina...1,8291,8672,0092,1152,3062,4412,4772,5872,4902,5222,620 Brazil...59,15365,12170,87273,60587,04477,58992,09191,314132,491143,497155,011 Canada24,78426,58128,22229,54231,05732,46733,89835,27436,46537,74238,74939,94241,00941,931 Chile9,30110,34411,31412,19013,45014,16015,35316,36017,85618,84919,85421,00721,73022,512 Colombia ,23919,84624,76024,69226,94228,807 Croatia2,7552,9133,1003,5043,5823,7083,7993,9324,0094,1244,2574,3484,4102,740 Czech Republic6,3746,7597,0927,2277,7434,6384,7525,1905,6339,53610,21810,236.10,647 Denmark3,4153,6703,8514,0044,1254,2194,2954,5924,6194,7014,7434,8214,9234,973 Estonia Finland3,0143,1803,3053,4613,6013,7553,8293,9534,0874,1834,2834,3514,3954,492 France ,15134,83549,67954,62762,01964,19766,24368,44870,792 Greece8,4808,9429,2669,70510,20710,64110,99411,34311,67412,06912,25512,47712,60812,832 Hong Kong.5,3005,6705,9376,3076,6356,9307,1717,4607,5807,8578,1978,5498,787 Hungary ,8078,7138,9129,0349,1359,211 Iceland Indonesia Iran ,24838,25040,30042,37044,45046,640 Ireland ,4873,6513,7753,8763,960 Israel3,3503,5283,7965,9956,3646,7477,1257,4727,8268,1348,4008,6998,9029,161 Jalisco (Mexico)1,6882,1102,4322,4633,1705,4556,3576,8657,2189,2229,91610,42110,76912,802 Japan205,139208,791220,196229,110236,334240,170249,718262,968271,471281,212289,415295,706301,545306,925 Rep. of Korea28,04631,01433,99338,79041,89144,33346,73048,67551,98956,39658,86063,34170,21175,042 Lebanon ,100.

Vol 2, ESRD, Ch 1320 Table 13.3 Number of prevalent ESRD patients and prevalence of ESRD, per million population, by country, (Continued) (a)Prevalent patients, counts Country Malaysia7,9519,18010,53111,94313,47915,08616,80518,82521,19123,44225,58928,23431,11333,887 Morelos (Mexico) ,4471,5611, Netherlands9,82710,20910,59411,00811,45711,97012,62313,14613,48814,05714,50814,92615,38415,887 New Zealand2,3562,5312,7152,8833,0003,1173,2453,3543,4593,6883,8323,8783,9884,156 Norway2,6102,7622,9173,0493,2553,3863,5103,6923,8954,0764,2014,3344,4564,574 Oman ,5351,7081,8362,0082,2062,382 Philippines3,861.1,8533,9224,3757,6767,4377,96710,55211,68313,67416,61919,21023,727 Poland ,78325,66525,63527,23628,22630,131 Portugal ,96516,01116,78817,55317,64118,345 Qatar ,0311,0881,1811,408 Romania.....5,5046,5787,9359,08810,86312,15013,41414,75216,162 Russia9,50810,77011,51713,17514,72016,48318,486.22,23424,24626,32727,98930,34934,680 Saudi Arabia ,33412,04012,63313,35614,17114,562 Scotland3,2453,3473,4573,6073,7133,8774,0114,1774,1864,2964,3694,4194,5494,614 Serbia ,2235,4125,651 Singapore3,6113,9124,1474,2814,4444,6654,9365,1655,4455,7015,9546,2976,6486,955 Slovenia ,0022,023 2,0572,077 South Africa ,5598,840 Spain....39,57828,36635,46241,54644,06739,70847,63250,61450,83750,565 Sweden6,3566,5816,8236,9727,2757,4087,7257,9298,0748,2918,5348,7808,8659,020 Taiwan34,00136,82840,36242,94545,36047,84950,25552,46256,02561,66865,12067,88970,66673,339 Thailand5,9637,225.15,00415,08313,74117,96726,45731,49635,11240,84547,98758,38571,037 Turkey18,39024,34826,26828,54931,25133,01442,99250,22153,85959,44362,47164,87761,67766,711 Ukraine ,985. United Kingdom^....34,02237,50240,10141,18843,47845,77547,49949,38351,04253,196 United States383,716403,431422,696441,103459,875478,651498,928518,883539,620561,848583,817603,287623,916645,697 Uruguay2,5512,7152,6752,8952,8073,0733,2043,3893,4073,4683,5323,5253,704 Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. ESRD prevalence is unadjusted and reflects prevalence at the end of each year. ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Japan and Taiwan includes dialysis only; Israel includes dialysis patients only for Data for France include 15 regions in 2006, 18 regions in 2007, 20 regions in 2008, and 22 regions in Data for Spain include 18 of 19 regions. Data for Belgium do not include patients younger than 20. Data for Indonesia represent the West Java region. a % change is calculated as the percent difference between the average prevalence in 2012 and 2013 and the average in 2000 and Abbreviations: ESRD, end-stage renal disease; sp., speaking;. signifies data not reported.

Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. The prevalence is unadjusted and reflects prevalence at the end of ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Japan and Taiwan include dialysis patients only. Data for Spain include 18 of 19 regions. Data for France include 22 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.9 Prevalence of treated ESRD, per million population, by age group and country, 2013 Vol 2, ESRD, Ch 1321 (a) years old

Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. The prevalence is unadjusted and reflects prevalence at the end of ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Japan and Taiwan include dialysis patients only. Data for Spain include 18 of 19 regions. Data for France include 22 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.9 Prevalence of treated ESRD, per million population, by age group and country, 2013 Vol 2, ESRD, Ch 1322 (a) years old

Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. The prevalence is unadjusted and reflects prevalence at the end of ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Japan and Taiwan include dialysis patients only. Data for Spain include 18 of 19 regions. Data for France include 22 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.9 Prevalence of treated ESRD, per million population, by age group and country, 2013 Vol 2, ESRD, Ch 1323 (a) years old

Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. The prevalence is unadjusted and reflects prevalence at the end of ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Japan and Taiwan include dialysis patients only. Data for Spain include 18 of 19 regions. Data for France include 22 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure 13.9 Prevalence of treated ESRD, per million population, by age group and country, 2013 Vol 2, ESRD, Ch 1324 (a)≥ 75 years old

Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. The prevalence is unadjusted and reflects prevalence at the end of ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Japan and Taiwan include dialysis patients only. Data for Spain include 18 of 19 regions. Data for France include 22 regions. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure Prevalence of treated ESRD, per million population, by sex and country, 2013 Vol 2, ESRD, Ch 1325

Figure Trends in the prevalence of treated ESRD, per million population, by country, Vol 2, ESRD, Ch 1326 Data source: Special analyses, USRDS ESRD Database. ESRD prevalence is unadjusted. Israel includes dialysis patients only from U.S. is shown for comparison purposes. Abbreviations: ESRD, end-stage renal disease. Ten countries having the highest % rise in ESRD prevalence from 2000/01 to 2012/13, plus the U.S.

Data source: Special analyses, USRDS ESRD Database & World Health Organization Global Health Expenditure database. Data presented only for countries from which relevant information was available. ESRD prevalence is unadjusted and was from 2013 for all countries except Bahrain for which it was from 2011 and Ukraine for which it was from a Central & Eastern Europe: Hungary, Romania, Czech Republic, Poland, Bosnia and Herzegovina, Serbia, Slovenia, Russian Federation, Turkey; Western Europe (except. UK, Ireland, & Nordic countries): France, Belgium (French-speaking), Belgium (Dutch-speaking), Spain, Portugal, Greece, Austria, Netherlands; UK, Ireland, Nordic Countries & ANZ: United Kingdom, Ireland, Sweden, Norway, Finland, Denmark, Iceland, Australia, New Zealand; North & Latin America: Argentina, Uruguay, Colombia, Brazil, Mexico (Jalisco), United States, Canada; Eastern & Southeast Asia: South Korea, Malaysia, Singapore, Thailand, Indonesia, Philippines, Japan; Middle East & Africa: Bahrain, Israel, Iran, Qatar, Saudi Arabia, South Africa. Abbreviations: ESRD, end-stage renal disease; PPP, purchasing power parity; pmp, per million population. Figure Prevalence of treated ESRD, per million population, and health spending per capita (PPP), by region, 2013 Vol 2, ESRD, Ch 1327

Data source: Special analyses, USRDS ESRD Database & United Nations Development Programme. Data presented only for countries from which relevant information was available. ESRD prevalence is unadjusted and was from 2013 for all countries except Bahrain for which it was from 2011 and Ukraine for which it was from a Central & Eastern Europe: Hungary, Romania, Czech Republic, Poland, Bosnia and Herzegovina, Serbia, Slovenia, Russian Federation, Turkey; Western Europe (except. UK, Ireland, & Nordic countries): France, Belgium (French-speaking), Belgium (Dutch-speaking), Spain, Portugal, Greece, Austria, Netherlands; UK, Ireland, Nordic Countries & ANZ: United Kingdom, Ireland, Sweden, Norway, Finland, Denmark, Iceland, Australia, New Zealand; North & Latin America: Argentina, Uruguay, Colombia, Brazil, Mexico (Jalisco), United States, Canada; Eastern & Southeast Asia: South Korea, Malaysia, Singapore, Thailand, Indonesia, Philippines, Japan; Middle East & Africa: Bahrain, Israel, Iran, Qatar, Saudi Arabia, South Africa. Abbreviations: ESRD, end-stage renal disease; pmp, per million population. Figure Prevalence of treated ESRD, per million population, and human development index, by region, 2013 Vol 2, ESRD, Ch 1328

Data source: Special analyses, USRDS ESRD Database & International Diabetes Federation, Diabetes Atlas. Data presented only for countries from which relevant information was available. ESRD prevalence is unadjusted and was from 2013 for all countries except Bahrain for which it was from 2011 and Ukraine for which it was from Diabetes percentage refers to the percentage of people ages who have type 1 or type 2 diabetes. a Central & Eastern Europe: Hungary, Romania, Czech Republic, Poland, Bosnia and Herzegovina, Serbia, Slovenia, Russian Federation, Turkey; Western Europe (except. UK, Ireland, & Nordic countries): France, Belgium (French-speaking), Belgium (Dutch-speaking), Spain, Portugal, Greece, Austria, Netherlands; UK, Ireland, Nordic Countries & ANZ: United Kingdom, Ireland, Sweden, Norway, Finland, Denmark, Iceland, Australia, New Zealand; North & Latin America: Argentina, Uruguay, Colombia, Brazil, Mexico (Jalisco), United States, Canada; Eastern & Southeast Asia: South Korea, Malaysia, Singapore, Thailand, Indonesia, Philippines, Japan; Middle East & Africa: Bahrain, Israel, Iran, Qatar, Saudi Arabia, South Africa. Abbreviations: ESRD, end-stage renal disease; pmp, per million population. Figure Prevalence of treated ESRD, per million population, and percentage of diabetes, by region, 2013 Vol 2, ESRD, Ch 1329

Table 13.4 Health development indicators and the prevalence of treated ESRD across countries, 2013 Vol 2, ESRD, Ch 1330 RegionCountry Health spending per capita Human Development Index Percentage of diabetes Prevalence of treated ESRD, pmp Central & Eastern Europe Bosnia and Herzegovina Croatia Czech Republic Estonia Hungary Poland Romania RussiaNA Serbia Slovenia Ukraine Eastern & Southeast Asia Hong KongNA Indonesia Japan Republic of Korea Malaysia Philippines Singapore Thailand Middle East & Africa Bahrain Iran Israel Lebanon Oman Qatar Saudi Arabia South Africa (Continue on the next slide)

Table 13.4 Health development indicators and the prevalence of treated ESRD across countries, 2013 (Continued) Vol 2, ESRD, Ch 1331 RegionCountry Health spending per capita Human Development Index Percentage of diabetes Prevalence of treated ESRD, pmp North & Latin America Argentina Brazil Canada Chile Colombia United States Uruguay UK, Ireland, Nordic European Union Countries, & Australia /New Zealand Australia Denmark Finland Iceland New Zealand Norway Sweden United Kingdom Western Europe Austria France Greece Netherlands Portugal Spain Data source: Special analyses, USRDS ESRD Database & World Health Organization Global Health Expenditure database, United Nations Development Programme, International Diabetes Federation, Diabetes Atlas. Data presented only for countries from which relevant information was available. ESRD prevalence is unadjusted and reflects the most recent available prevalence since Diabetes percentage refers to the percentage of people ages who have type 1 or type 2 diabetes. Abbreviations: ESRD, end-stage renal disease; PPP, purchasing power parity; pmp, per million population.

Data source: Special analyses, USRDS ESRD Database. The prevalence is unadjusted and reflects prevalence at the end of ^United Kingdom: England, Wales, Northern Ireland (Scotland data reported separately). Data for Indonesia represent the West Java region. Data for Spain include 18 of 19 regions. Data for France include 22 regions. Data for Belgium do not include patients younger than 20. Abbreviations: sp., speaking. Figure Prevalence of dialysis, per million population, by country, 2013 Vol 2, ESRD, Ch 1332

Figure Trends in the prevalence of dialysis, per million population, by country, Vol 2, ESRD, Ch 1333 Data source: Special analyses, USRDS ESRD Database. The prevalence is unadjusted and reflects prevalence of dialysis at the end of each year. U.S. is shown for comparison purposes. Abbreviations: ESRD, end-stage renal disease. Ten countries having the highest % rise in dialysis prevalence from 2000/01 to 2012/13, plus the U.S.

Table 13.5 Trends in the prevalence of dialysis, per million population, by country, Vol 2, ESRD, Ch 1334 Country % change from 2000/01 to 2012/13 Argentina Australia Austria Bahrain Bangladesh Belgium, Dutch sp Belgium, French sp Bosnia and Herzegovina Brazil Canada Chile Colombia Croatia Czech Republic Denmark Estonia Finland France Greece Hong Kong Hungary Iceland Indonesia Iran Ireland Israel Italy Jalisco (Mexico) Japan Rep. of Korea Kuwait Lebanon Malaysia (Continue on the next slide)

Table 13.5 Trends in the prevalence of dialysis, per million population, by country, (Continued) Vol 2, ESRD, Ch 1335 Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. The prevalence is unadjusted and reflects prevalence of dialysis at the end of each year. ^United Kingdom: England, Wales, & Northern Ireland (Scotland data reported separately). Data for France include 15 regions in 2006, 18 in 2007, 20 in 2008, and 22 in Data for Belgium do not include patients younger than 20. Data for Spain include 18 of 19 regions. a % change is calculated as the percent difference between the average prevalence in 2012 and 2013 and the average in 2000 and Abbreviations: sp., speaking;. signifies data not reported. Country % change from 2000/01 to 2012/13 Morelos (Mexico) Netherlands New Zealand Norway Oman Philippines Poland Portugal Qatar Romania Russia Saudi Arabia Scotland Serbia Singapore Slovenia South Africa Spain Sweden Switzerland Taiwan Thailand Turkey United Kingdom^ United States Uruguay

Data source: Special analyses, USRDS ESRD Database. Denominator is calculated as the sum of patients receiving HD, PD, or Home HD; does not include patients with other/unknown modality. ^United Kingdom: England, Wales, & Northern Ireland (Scotland data reported separately). Data for Spain include 18 of 19 regions. Data for France include 22 regions. Data for Belgium do not include patients younger than 20. Abbreviations: CAPD, continuous ambulatory peritoneal dialysis; APD, automated peritoneal dialysis; IPD, intermittent peritoneal dialysis; ESRD, end-stage renal disease; HD, hemodialysis; PD, peritoneal dialysis; sp., speaking. Figure Distribution of the percentage of prevalent dialysis patients using in-center HD, home HD, or peritoneal (CAPD/APD/IPD), 2013 Vol 2, ESRD, Ch 1336

Table 13.6 Distribution of the percentage of prevalent dialysis patients using in-center HD, home HD, or peritoneal dialysis (CAPD/APD/IPD), Vol 2, ESRD, Ch 1337 (a)In-center HD Country Argentina Australia Austria Bahrain Bangladesh Belgium, Dutch sp Belgium, French sp Bosnia and Herzegovina Brazil Canada Chile Colombia Croatia Czech Republic Denmark Estonia Finland France Greece Hong Kong Hungary Iceland Iran Ireland Israel Italy Jalisco (Mexico) Japan (Continue on the next slide)

Table 13.6 Distribution of the percentage of prevalent dialysis patients using in-center HD, home HD, or peritoneal dialysis (CAPD/APD/IPD), (Continued) Vol 2, ESRD, Ch 1338 (a)In-center HD Country Rep. of Korea Kuwait Lebanon Malaysia Morelos (Mexico) Netherlands New Zealand Norway Oman Philippines Poland Portugal Qatar Romania Russia Saudi Arabia Scotland Serbia Singapore Slovenia South Africa Spain Sweden Switzerland Taiwan Thailand Turkey United Kingdom^ United States Uruguay (Continue on the next slide)

Table 13.6 Distribution of the percentage of prevalent dialysis patients using in-center HD, home HD, or peritoneal dialysis (CAPD/APD/IPD), (Continued) Vol 2, ESRD, Ch 1339 (Continue on the next slide) (b) CAPD/APD/IPD Country Argentina Australia Austria Bahrain Bangladesh Belgium, Dutch sp Belgium, French sp Bosnia and Herzegovina Brazil Canada Chile Colombia Croatia Czech Republic Denmark Estonia Finland France Greece Hong Kong Hungary Iceland Iran Ireland Israel Italy Jalisco (Mexico) Japan

Table 13.6 Distribution of the percentage of prevalent dialysis patients using in-center HD, home HD, or peritoneal dialysis (CAPD/APD/IPD), (Continued) Vol 2, ESRD, Ch 1340 (Continue on the next slide) (b) CAPD/APD/IPD Country Rep. of Korea Kuwait Lebanon Malaysia Morelos (Mexico) Netherlands New Zealand Norway Oman Philippines Poland Portugal Qatar Romania Russia Saudi Arabia Scotland Serbia Singapore Slovenia South Africa Spain Sweden Switzerland Taiwan Thailand Turkey United Kingdom^ United States Uruguay

Table 13.6 Distribution of the percentage of prevalent dialysis patients using in-center HD, home HD, or peritoneal dialysis (CAPD/APD/IPD), (Continued) Vol 2, ESRD, Ch 1341 (Continue on the next slide) (c) Home HD Country Argentina Australia Austria Bahrain Bangladesh0.0.. Belgium, Dutch sp Belgium, French sp Bosnia and Herzegovina Brazil Canada Chile0.0 Colombia Croatia0.0.. Czech Republic Denmark Estonia Finland France Greece0.0 Hong Kong Hungary Iceland Iran Ireland Israel0.0 Italy Jalisco (Mexico)0.0 Japan

Table 13.6 Distribution of the percentage of prevalent dialysis patients using in-center HD, home HD, or peritoneal dialysis (CAPD/APD/IPD), (Continued) Vol 2, ESRD, Ch 1342 Data source: Special analyses, USRDS ESRD Database. Denominator is calculated as the sum of patients receiving HD, PD, or Home HD; does not include patients with other/unknown modality. Data prior to 2013 represents information on CAPD/CCPD. ^United Kingdom: England, Wales, & Northern Ireland (Scotland data reported separately). Data for Spain include 18 of 19 regions. Data for France include 22 regions. Data for Belgium do not include patients younger than 20. Abbreviations: CAPD, continuous ambulatory peritoneal dialysis; APD, automated peritoneal dialysis; IPD, intermittent peritoneal dialysis; CCPD, continuous cycling peritoneal dialysis; ESRD, end-stage renal disease; HD, hemodialysis; PD, peritoneal dialysis; sp., speaking. (c) Home HD Country Rep. of Korea0.0 Kuwait Lebanon Malaysia Morelos (Mexico) Netherlands New Zealand Norway Oman Philippines Poland Portugal Qatar Romania Russia0.0. Saudi Arabia Scotland Serbia Singapore0.1 Slovenia South Africa Spain Sweden Switzerland Taiwan Thailand0.0. Turkey United Kingdom^ United States Uruguay0.0

Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. All rates are unadjusted. ^United Kingdom: England, Wales, & Northern Ireland (Scotland data reported separately). Data for Belgium do not include patients younger than 20. Data for France include 22 regions. Transplant data for Romania are limited to that available in dialysis center reports and includes only non- preemptive transplants. Data for Spain include all regions. Abbreviations: sp., speaking. Figure Kidney transplantation rate, per million population, by country, 2013 Vol 2, ESRD, Ch 1343 (a) Per million population

Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. All rates are unadjusted. ^United Kingdom: England, Wales, & Northern Ireland (Scotland data reported separately). Data for Belgium do not include patients younger than 20. Data for France include 22 regions. Transplant data for Romania are limited to that available in dialysis center reports, and include only non- preemptive transplants. Data for Spain include all regions. Abbreviations: sp., speaking. Figure Kidney transplantation rate, per 1000 dialysis patients, by country, 2013 Vol 2, ESRD, Ch 1344 (b) Per 1000 dialysis patients

Table 13.7 Kidney transplantation rates, per million population, by country Vol 2, ESRD, Ch 1345 Country % change from 2000/01 to 2012/13 Argentina Australia Austria Bahrain Bangladesh Belgium, Dutch sp Belgium, French sp Bosnia and Herzegovina Brazil Canada Chile Colombia Croatia Czech Republic Denmark Estonia Finland France Greece Hong Kong Hungary Iceland Iran Ireland Israel Jalisco (Mexico) Japan Rep. of Korea Kuwait Lebanon Malaysia (Continue on the next slide)

Table 13.7 Kidney transplantation rates, per million population, by country (Continued) Vol 2, ESRD, Ch 1346 Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. Prevalence is unadjusted. ^United Kingdom: England, Wales, & Northern Ireland (Scotland data reported separately). Data for France include 15 regions in 2006, 18 in 2007, 20 in 2008, and 22 in Data for Belgium do not include patients younger than 20. There is underreporting of prevalent transplant patients in Turkey. a % change is calculated as the percent difference between the average prevalence in 2012 and 2013 and the average in 2000 and Abbreviations: ESRD, end-stage renal disease; sp., speaking;. signifies data not reported. Country % change from 2000/01 to 2012/13 Morelos (Mexico) Netherlands New Zealand Norway Oman Philippines Poland Portugal Qatar Romania Russia Saudi Arabia Scotland Serbia Singapore Slovenia South Africa Spain Sweden Switzerland Taiwan Thailand Turkey Ukraine United Kingdom^ United States Uruguay

Figure Kidney transplantation rate, per million population, by country, Vol 2, ESRD, Ch 1347 Data source: Special analyses, USRDS ESRD Database. All rates are unadjusted. Data for Croatia are missing from , as indicated by the dashed line. Abbreviations: ESRD, end-stage renal disease. Ten countries having the highest % rise in kidney transplantation rate from 2000/01 to 2012/13, plus the U.S.

Data source: Special analyses, USRDS ESRD Database. Denominator is calculated as the sum of deceased, living donor, and unknown transplants. ^United Kingdom: England, Wales, & Northern Ireland (Scotland data reported separately). Data for France include 22 regions. Abbreviations: ESRD, end-stage renal disease. Figure Distribution of the percentage of kidney transplantations, by kidney donor type and country, 2013 Vol 2, ESRD, Ch 1348

Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. Prevalence is unadjusted. Data for France include 22 regions. ^United Kingdom: England, Wales, & Northern Ireland (Scotland data reported separately). Data for Belgium do not include patients younger than 20. Abbreviations: ESRD, end-stage renal disease; sp., speaking. Figure Prevalence of treated ESRD patients with a functioning kidney transplant, per million population, by country, 2013 Vol 2, ESRD, Ch 1349

Table 13.8 Trends in the prevalence of treated ESRD patients with a functioning kidney transplant, per million population, by country, Vol 2, ESRD, Ch 1350 Country % change from 2000/01 to 2012/13 Argentina Australia Austria Bahrain Bangladesh Belgium, Dutch sp Belgium, French sp Bosnia and Herzegovina Brazil Canada Chile Colombia Croatia Czech Republic Denmark Estonia Finland France Greece Hong Kong Hungary Iceland Iran Ireland Israel Jalisco (Mexico) Japan Rep. of Korea Malaysia (Continue on the next slide)

Table 13.8 Trends in the prevalence of treated ESRD patients with a functioning kidney transplant, per million population, by country, (Continued) Vol 2, ESRD, Ch 1351 Data source: Special analyses, USRDS ESRD Database. Data presented only for countries from which relevant information was available. Prevalence is unadjusted. ^United Kingdom: England, Wales, & Northern Ireland (Scotland data reported separately). Data for France include 15 regions in 2006, 18 in 2007, 20 in 2008, and 22 in Data for Belgium do not include patients younger than 20. There is underreporting of prevalent transplant patients in Turkey. a % change is calculated as the percent difference between the average prevalence in 2012 and 2013 and the average in 2000 and Abbreviations: ESRD, end-stage renal disease; sp., speaking;. signifies data not reported. Country % change from 2000/01 to 2012/13 Morelos (Mexico) Netherlands New Zealand Norway Oman Philippines Poland Portugal Qatar Romania Russia Saudi Arabia Scotland Serbia Singapore Slovenia South Africa Spain Sweden Taiwan Thailand Turkey Ukraine United Kingdom^ United States Uruguay